Abstract
The Results of a Phase ⅢClinical Trial for a Novel Enzymatic Debridement Agent KMW-1 in Japanese Patients with Deep Dermal Burn and Deep Burn
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have